Richard Cathomas about Immunotherapy in muscle-invasive bladder cancer
About this episode
Dr. Richard Cathomas, medical oncologist from Zurich in Switzerland discusses Immunotherapy in muscle-invasive bladder cancer.
He goes into the mechanism of action of immunotherapy and why could it work well in bladder cancer.
Where do we currently stand with the use of immunotherapy in the NEOADJUVANT setting of muscle invasive bladder cancer? And what is currently the best place to integrate immunotherapy for METASTATIC bladder cancer?
Prof. Dr. Cathomas closes with the answer to the question of why some patients benefit much more than others from immunotherapy.
Prof. Dr. Richard Cathomas is oncologist panel member on the EAU Guidelines for muscle-invasive bladder cancer.
Get every episode summarized
Each time EAU Podcasts publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.
Email me new episodesFree for 3 shows. No card needed.
No transcript yet
This episode has not been transcribed. Request it and it moves to the front of the queue.
More episodes
More from EAU Podcasts
EAUN edition - No place to go: Homelessness & Incontinence
EAU Podcasts
EAU Section of Genitourinary Reconstructive Surgeons: Management of short bulbar...
EAU Podcasts
History Office: Ongoing discoveries from the life of Joaquín Albarrán (1860-1912...
EAU Podcasts
PEACE 2 results: Evaluating pelvic RT for very high-risk PCa
EAU Podcasts